AMLX R&D Expenses
Amylyx Pharmaceuticals Inc · R&D Expenses
AMLX R&D Expenses
Latest reported$92.34Mperiod ending
AMLX TTM R&D Expenses ($35.66M → $92.34M)
TTM R&D Expenses
High-resolution chart · PNG
AMLX r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 92,338,000 | |
| 95,646,000 | |
| 90,155,000 | |
| 91,942,000 | |
| 93,324,000 | |
| 89,387,000 | |
| 103,876,000 | |
| 125,898,000 | |
| 134,698,000 | |
| 140,603,000 | |
| 128,187,000 | |
| 106,086,000 | |
| 100,963,000 | |
| 96,178,000 | |
| 93,450,000 | |
| 84,031,000 | |
| 71,970,000 | |
| 58,640,000 | |
| 44,040,000 | |
| 35,659,000 |